PURPOSE: Craniospinal irradiation (CSI) has greatly increased survival rates for patients with a diagnosis of medulloblastoma and other primitive neuroectodermal tumors. However, as it includes exposure of a large volume of healthy tissue to unwanted doses, there is a strong concern about the complications of the treatment, especially for the children. To estimate the risk of second cancers and other unwanted effects, out-of-field dose assessment is necessary. The purpose of this study is to evaluate and compare out-of-field doses in pediatric CSI treatment using conventional and advanced photon radiotherapy (RT) and advanced proton therapy. To our knowledge, it is the first such comparison based on in-phantom measurements. Additionally, for out-of-field doses during photon RT in this and other studies, comparisons were made using analytical modeling. METHODS: In order to describe the out-of-field doses absorbed in a pediatric patient during actual clinical treatment, an anthropomorphic phantom, which mimics the 10-year-old child, was used. Photon 3D-conformal RT (3D-CRT) and two advanced, highly conformal techniques: photon volumetric-modulated arc therapy (VMAT) and active pencil beam scanning (PBS) proton RT were used for CSI treatment. Radiophotoluminescent and poly-allyl-diglycol-carbonate nuclear track detectors were used for photon and neutron dosimetry in the phantom, respectively. Out-of-field doses from neutrons were expressed in terms of dose equivalent. A two-Gaussian model was implemented for out-of-field doses during photon RT. RESULTS: The mean VMAT photon doses per target dose to all organs in this study were under 50% of the target dose (i.e., <500 mGy/Gy), while the mean 3D-CRT photon dose to oesophagus, gall bladder, and thyroid, exceeded that value. However, for 3D-CRT, better sparing was achieved for eyes and lungs. The mean PBS photon doses for all organs were up to three orders of magnitude lower compared to VMAT and 3D-CRT and exceeded 10 mGy/Gy only for the oesophagus, intestine, and lungs. The mean neutron dose equivalent during PBS for eight organs of interest (thyroid, breasts, lungs, liver, stomach, gall bladder, bladder, prostate) ranged from 1.2 mSv/Gy for bladder to 23.1 mSv/Gy for breasts. Comparison of out-of-field doses in this and other phantom studies found in the literature showed that a simple and fast two-Gaussian model for out-of-field doses as a function of distance from the field edge can be applied in a CSI using photon RT techniques. CONCLUSIONS: PBS is the most promising technique for out-of-field dose reduction in comparison to photon techniques. Among photon techniques, VMAT is a preferred choice for most of out-of-field organs and especially for the thyroid, while doses for eyes, breasts, and lungs are lower for 3D-CRT. For organs outside the field edge, a simple analytical model can be helpful for clinicians involved in treatment planning using photon RT but also for retrospective data analysis for cancer risk estimates and epidemiology in general.

Belgium Nuclear Research Center Mol Belgium

Danish Center for Particle Therapy Aarhus Denmark

Department of Physics Faculty of Science University of Zagreb Zagreb Croatia

Faculty of Medicine Osijek J J Strossmayer University of Osijek Osijek Croatia

Institute of Nuclear Physics Polish Academy of Sciences Krakow Poland

Nuclear Physics Institute of the CAS Řež Czech Republic

Osijek University Hospital Osijek Croatia

Ruđer Bošković Institute Zagreb Croatia

University of Newcastle Newcastle upon Tyne UK

Zobrazit více v PubMed

Dhall G. Medulloblastoma. J Child Neurol. 2009;24:1418-1430.

Friedmann DL, Whitton J, Leisenring W, Mertens AC. Subsequent neoplasms in 5 year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1083-1095.

Fossati P, Ricardi U, Orecchia R. Pediatric medelloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev. 2009;35:79-96.

Cox MC, Kusters JM, Gidding CE, et al. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: a prospective analysis. Radiat Oncol. 2015;10:241.

Parker W, Filion E, Roberge D, Freeman C. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints and competing risks. Int J Radiat Oncol Biol Phys. 2007;69:251-257.

Kusters JM, Louwe RJW, van Kollenburg PGM, et al. Optimal normal tissue sparinf in craniospinal axis radiation using IMRT with daily infractionally modulated junction. Int J Radiat Oncol Biol Phys. 2011;81:1405-1414.

Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84:967-996.

Lee YK, Brooks CJ, Bedford JL, Warrington AP, Saran FH. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning. Int J Radiat Oncol Biol Phys. 2011;82:1006-1012.

Lopez Guerra JL, Marrone I, Jaen J, et al. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma. Clin Transl Oncol. 2014;16:96-101.

St Clair W, Adams JA, Bues M, et al. Advantage of protons compared to conventional x-ray od IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys. 2004;58:727-734.

Lee CT, Bilton SD, Famiglietti RM, et al. Treatment palnning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do proton compare with other conformal techniques. Int J Radiat Oncol Biol Phys. 2005;63:362-372.

ICRP Publication 92: Relative Biological Effectiveness (RBE), Quality Factor (Q), and Radiation Weighting Factor (wR) 2003.

Azaiez F, Bracco A, Dobeš J, et al. Nuclear Physics for Medicine. NuPECC; 2014.

Newhauser W, Zhang R. The physics of proton therapy. Phys Med Biol. 2015;60:R155.

Kry SF, Bednarz B, Howell RM, et al. AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys. 2017;44:e391-e429.

Athar BS, Paganetti H. Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans. Radiat Oncol. 2011;98:87-92.

Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol. 2012;7:116.

Rehman JU, Tailor RC, Isa M, et al. Evaluation of secondary cancer risk in spine radiotherapy using 3DCRT, IMRT and VMAT: a phantom study. Med Dos. 2014;40:70-75.

Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD. A comparative study on the risk of radiogenic second cancers and cardiac mortality in a set of paediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol. 2014;113:84-88.

Seravalli E, Bosman M, Lassen-Ramshad Y, et al. Dosimetric comparison of five different techniques for craniospinal irradiation across 15 Eropean centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group). Acta Oncol. 2018;57:1240-1249.

Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by comercial treatment planning system. Phys Biol Med. 2010;55:6999-7008.

Huang JY, Followill DS, Wang XA, Kry SF. Accuracy and sources of error of out-of-field dose calculated by a commercial treatments planning system for intensity-modulated radiation therapy treatments. J Appl Clin Med Phys. 2013;14:4139.

Miljanić S, Bessieres I, Bordy J-M, et al. Clinical simulations of prostate radiotherapy using BOMAB-like phantoms: results for photons. Radiat Meas. 2013;57:35-47.

Majer M, Stolarczyk L, De Saint-Hubert M, et al. Out-of-field doses measurements for 3D conformal and intensity modulated radiotherapy of a paediatric brain tumour. Radiat Prot Dosim. 2017;176:331-340.

Sanchez-Nieto B, Medina-Ascanio KN, Rodriguez-Mongua JL, Doerner E, Espinoza I. Study of out-of-field dose in photon radiotherapy: a commercial treatment planning system versus measurements and Monte Carlo simulations. Med Phys. 2020;47:4616-4625.

Taddei PJ, Mirkovic P, Fontenot JD, et al. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams. Phys Med Biol. 2009;54:2259-2275.

Newhauser WD, Fontenot JD, Mahajan A, et al. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 2009;54:2277-2201.

Athar BS, Bednarz B, Seco J, Hancox C, Paganetti H. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patints. Phys Med Biol. 2010;55:2879-2891.

Zhang R, Howell RM, Giebeler A, Tadder PJ, Mahajan A, Newhauser WD. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol. 2013;58:807-823.

Yeom SY, Kuzmin G, Griffin K, et al. A Monte Carlo model for organ dose reconstruction of patients in pencil beam scanning (PBS) proton therapy for epidemiologic studies of late effects. J Radiol Prot. 2020;40:225-242.

Agosteo S, Birattari C, Caravaggio M, Silari M, Tosi G. Secondary neutron and photon dose in proton therapy. Radiother Oncol. 1998;48:293-305.

Fontenot J, Taddei P, Zheng Y, Mirkovic D, Jordan T, Newhauser W. Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer. Phys Med Biol. 2008;53:1677-1688.

Taddei PJ, Fontenot JD, Zheng Y, et al. Reducing stray radiation dose to pediatric receiving passively scattered proton radiotherapy for prostate cancer. Phys Biol Med. 2008;53:2131-2147.

Hood C, Kron T, Hamilton C, et al. Correlation of 3D-planned and measured dosimetry of photon and electron craniospinal radiation in a pediatric anthropomorphic phantom. Radiother Oncol. 2005;77:111-116.

De Saint-Hubert M, Verellen D, Poels K, et al. Out-of-field doses from paediatric craniospinal irradiations using 3D-CRT, IMRT, helical tomotherapy and electron-based therapy. Phys Med Biol. 2017;62:5293-5311.

Taddei PJ, Jalbout W, Howell RM, et al. Analytical model for out-of-field dose in photon craniospinal irradiation. Phys Med Biol. 2013;58:7463-7479.

Pollul G, Bostel T, Grossmann S, et al. Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison. Radiat Oncol. 2020;15:256-265.

Ajithumar T, Horan G, Padovani L, et al. SIOPE - brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radioptherapy. Radiother Oncol. 2018;28(2):192-197.

Giebeler A, Newhauser WD, Amos RA, Mahajan A, Homann K, Howell RM. Standardized treatment planning methodology for passively scattered proton craniospinal irradiation. Radiat Oncol. 2013;8:32.

Stokkevag CH, Engeseth G-M, Ytre-Hauge KS, et al. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncol. 2014;53:1048-1057.

ICRU. ICRU Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy 1993. ICRU Report 62: Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU 50) 1999. ICRU Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy 2007. ICRU REPORT 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy 2010.

NRC. Health Risks from Exposure to Low Levels of Ionising Radiation: BEIR VII Phase 2. National Research Council of the National Academies; 2006.

ATGC. Explanation Material of RPL Glass Dosimeter: Small Element System. Asahi Techno Glass Corporation; 2007.

Vekić B, Ban R, Miljanić S. Secondary standard dosimetry laboratory at the ruđer bošković institute. Arh Hig Rada Toksikol. 2006;57:189-194.

Miljanić S. Intercomparison of dosimeters for non-target organ dose measurements in radiotherapy - Activity of EURADOS WG9. Proceedings of The 6th International Workshop on Ionizing Radiation Monitoring. Chyioda Technol Corporation; 2010:95-107.

Knežević Ž, Stolarczyk L, Besseirs I, et al. Photon dosimetry methods outside the target volume in radiation therapy: optically stimulated luminescence (OSL), thermoluminescence (TL) and radiophotoluminescence (RPL) dosimetry. Radiat Meas. 2013;53:10-20.

Jadrničkova I, Spurny F. To the spectrometry of linear energy transfer in charged particle beams by means of track-etch detectors. Radiat Meas. 2008;43:S191.

Pachnerova Brabcova K, Ambrožova I, Koliskova Z, Malušek A. Uncertainties in linear energy transfer spectra measured with track-etched detectors in space. Nucl Instrum Meth A. 2013;713:5-10.

Stolarczyk L, Trinkl S, Romero-Exposito M, et al. Dose distribution of scattered radiation in water phantom for proton pencil beam - EURADOS. Phys Med Biol. 2018;63:085017.

Zhang R, Perez-Andujar A, Fontenot JD, Taddei PJ, Newhauser WD. An analytical model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy. Phys Med Biol. 2010;55:6975-6985.

Indelicato DJ, Bates JE, Vega RBM. Second tumor risk in children treated with proton therapy. Ped Blood Cancer. 2021;68:e28941.

Halg R, Besserer J, Boschung M, Mayer S, Lomax AJ, Schneider U. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy. Phys Med Biol. 2014;59:2457-2468.

Knežević Ž, Ambrozova I, Domingo C, et al. Comparison of response of passive dosimetry systems in scanning proton radiotherapy - a study using paediatric anthropomorphic phantoms. Radiat Prot Dos. 2018;180:256-260.

Romero-Exposito M, Domingo C, Sanchez-Doblado F, Ortega-Galabert O, Gallego S. Experimental evaluation of neutron dose in radiotherapy patients: which dose?. Med Phys. 2016;43:360-367.

Schneider U, Halg RA, Lomax T. Neutrons in active proton therapy: parametrization of dose and dose equivalent. Z Med Phys. 2017;27:113-123.

Gallagher KJ, Taddei PJ. Analytical model toestimate equivalent dose from internal neutrons in proton therapy of children with intracranial tumors. Radiat Prot Dos. 2019;183:360-468.

Jagetic LJ, Newhauser WD. A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy. Phys Med Biol. 2015;60:4753-4775.

Baradaran-Ghahfarokhi M, Reynose F, Sun B, et al. Monte Carlo-based analytic model of neutron dose equivalent for a mevion gantry-mounted passively scattered proton system for craniospinal irradiation. Med Phys. 2020;47:4509-4521.

Miljanić S, Ranogajec-Komor M, Blagus S, Palfalfi J, Pazmandi T, Sandor D. Response of radiophotoluminescent dosimeters to neutrons. Radiat Meas. 2008;43:1068-1071.

Bordy J-M, Bessieres I, D'Agostino E, et al. Radiotherapy out-of-field dosimetry: experimental and computational results for photons in water tank. Radiat Meas. 2013;53:29-34.

Raah JE, Oh DH, Kim D-H, et al. Dosimetric evaluation of a glass dosimeter for proton beam measurements. Appl Rad Isot. 2012;70:1616-1623.

Out-of-Field Doses Produced by a Proton Scanning Beam Inside Pediatric Anthropomorphic Phantoms and Their Comparison With Different Photon Modalities

Neutron Radiation Dose Measurements in a Scanning Proton Therapy Room: Can Parents Remain Near Their Children During Treatment?